Protective Role of TNF-?? in Respiratory Syncytial Virus Infection In Vitro and In Vivo
- 1 May 1996
- journal article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 311 (5), 201-204
- https://doi.org/10.1097/00000441-199605000-00001
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoids.The Journal of Experimental Medicine, 1995
- Interaction of alveolar macrophages and respiratory syncytial virusJournal of Immunological Methods, 1994
- In vivo production of tumour necrosis factor-α and interleukin-6 in BALB/c mice inoculated intranasally with a high dose of respiratory syncytial virusJournal of Medical Virology, 1994
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.The Journal of Experimental Medicine, 1993
- Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis.The Journal of Experimental Medicine, 1989
- Respiratory Syncytial Virus Infection of Human Cord and Adult Blood Monocytes and Alveolar MacrophagesAmerican Review of Respiratory Disease, 1989
- Primary respiratory syncytial virus infection in miceJournal of Medical Virology, 1988
- Tumour necrosis factors α and β inhibit virus replication and synergize with interferonsNature, 1986
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986